Exelixis
EXEL
#1622
Rank
C$13.70 B
Marketcap
$48.95
Share price
2.47%
Change (1 day)
57.91%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company